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Flavonoids are the largest class of naturally occurring polyphenolic phytochemicals in terms of number of
structurally distinct molecules, with over 6,000 unique structures. They are particularly abundant in plant-based
foods that are considered health-promoting. Upon ingestion, flavonoids are only partially absorbed, and gut
microbiota plays a significant role in their metabolism. The health benefits of flavonoids are generally associated
with their antioxidant and anti-inflammatory activities, although the potency varies widely even among flavonoids
of the same subclass.
The enzymatic pathways of flavonoid metabolism in gut bacteria are largely unresolved. Flavonoids are not
natural substrates of gut bacterial enzymes. Consequently, reactions of flavonoid metabolism have been
attributed to more general classes of enzymes. However, the specific enzymes that belong to these classes and
the bacterial species carrying the enzymes remain to be elucidated. To systematically characterize promiscuous
enzyme activity on flavonoids, we developed a prediction tool that is based on chemical reaction similarity. The
algorithm can take a single enzyme or a list of enzymes from an organism or a batch culture to match microbial
enzymes with their non-native flavonoid substrates and orphan reactions. We successfully predicted the
promiscuous activity of known flavonoid-metabolizing bacterial enzymes.
In vitro studies have shown that flavonoids can engage specific cellular receptors, but it remains to be
established if and which of the pathways regulated by these receptors are responsible for the flavonoids’
beneficial effects in vivo. Interestingly, these receptors can also bind phenolic acids, which are known metabolic
products of flavonoids. In contrast to many flavonoid compounds, these metabolites are well absorbed in the
intestine and are typically found at higher plasma concentrations. This raises the intriguing question whether
flavonoid derived metabolites are quantitatively important ligands for the Aryl Hydrocarbon Receptor (AhR),
nuclear receptor 4A (NR4A), and other flavonoid relevant receptors.
In this study, we investigate the microbial metabolism of a model flavonoid, naringenin, into its C-ring cleavage
product, 3,4-hydroxyphenylpropanoic acid (34HPPA) through naringenin chalcone as the intermediate. Using
metabolic modeling, we predicted that this metabolism in gut bacteria proceeds through a chalcone synthaselike bacterial polyketide synthase and confirmed this prediction using in vitro culture experiments and LCMS/MS
techniques. We also showed that the formation of 34HPPA in a mixed bacterial community depends on
microbiota composition due to the rarity of the chalcone synthase-like enzyme. Our gene expression assays for
induction of CYP1A1, CYP1B1 and UGT1A1 in human epithelial cells showed that naringenin chalcone is an
AhR ligand, while naringenin is inactive. 34HPPA alone did not affect AhR-responsive gene expression, but it
significantly enhanced CYP1A1 and CYP1B1 expressions when combined with the AhR agonist TCDD (10 nM),
indicating a synergistic effect. However, our binding studies, as orphan receptor gene expressions cannot be
linked to their functions directly, on naringenin and 34HPPA with NR4A1/2 receptors showed that only
naringenin has strong binding affinity. Having found that naringenin and its ring cleavage metabolites exhibit
different AhR agonist activities and NR4A binding affinities, we next investigated whether they also show
different immunomodulatory effects. We observed a significant decrease in IL-1ß induced IL-8 expression upon
naringenin treatment in Caco-2 cells, whereas 34HPPA had no effect. Our findings underscore the importance
of elucidating the pathways and products of gut bacterial flavonoid metabolism. Prospectively, the predictionvalidation methodology developed in this work could be used to systematically characterize the metabolism of
flavonoid metabolites and identify the responsible enzymes and species, directly linking the formation of
bioactive flavonoids to abundance of specific gut bacteria.

